Ayurvedic Herbs for Fatty Liver: What the Evidence Says

Quick answer. The Ayurvedic herbs most often used to support liver health in fatty liver are Kutki (Picrorhiza kurroa), turmeric (Curcuma longa), Bhumi Amla (Phyllanthus niruri) and Triphala. Be honest about the evidence: none is a proven cure for fatty liver. Human data is limited and mixed, and the strongest reversal lever remains diet, weight loss and exercise. Fatty liver is a medical condition — do not self-treat it. Use herbs only as an adjunct, under your doctor's supervision.

Most Indians first hear the words "fatty liver" at a routine health check or an ultrasound they went in for entirely different reasons, and the first instinct is to search for a herb that will fix it. The internet obliges with a wall of pages promising to "reverse fatty liver naturally," which is exactly the kind of disease-cure claim that is both unsupported and not allowed under Indian advertising law.

This guide does the opposite. It answers which Ayurvedic herbs are genuinely studied for liver health, grades the evidence for each one truthfully (animal-only here, a different liver disease there, modest-and-contested for turmeric), and tells you plainly where the real reversal evidence sits.

You will leave knowing what is and isn't supported, without overpromising, and knowing why a diagnosed fatty liver is something to take to your doctor, not to self-treat with herbs.

---

What "fatty liver" is — the one honest truth up front

Fatty liver, clinically non-alcoholic fatty liver disease (NAFLD), is the build-up of excess fat inside liver cells, usually linked to weight, blood sugar and lipid levels. It is a recognised medical condition, not a vague "imbalance," and at its more advanced stages it can progress to inflammation and fibrosis.

Here is the honest truth most pages bury: the intervention with the strongest evidence for reversing liver fat is lifestyle — gradual weight loss, a better diet, more movement and managing blood sugar. Herbs are, at best, an adjunct that may support liver health alongside that work. They are not a substitute for it, and none has been shown to cure fatty liver.

In traditional Ayurveda, the liver (yakrit) is described as a seat of Pitta (specifically Ranjaka Pitta), and fatty liver is often framed as a Kapha–Medas (fat-tissue) imbalance to be addressed through deepana-pachana (kindling digestion and metabolism) and reducing ama (metabolic residue). These are traditional concepts, useful for framing, not clinical descriptions of physiology, and not evidence of what any single herb does.

So treat the rest of this article as a map of support, not treatment, and read the cautions section before acting on any of it.

---

Which Ayurvedic herbs are used to support liver health in fatty liver?

The Ayurvedic herbs most commonly used to support liver health in fatty liver are **Kutki (Picrorhiza kurroa), turmeric (Curcuma longa), Bhumi Amla (Phyllanthus niruri) and Triphala, with the classical formulation Arogyavardhini Vati** sometimes added under practitioner care. None is a proven cure; the evidence ranges from animal-only to small, mixed human trials, so each belongs only as an adjunct to medical care and lifestyle change.

Here is the evidence grade for each, at a glance:

Herb	Botanical name	What the strongest evidence is	Honest grade for fatty liver
Kutki	Picrorhiza kurroa	Reversed fatty infiltration in a rat study; a human trial existed only in viral hepatitis, not NAFLD	Animal-only for NAFLD; human fatty-liver trials lacking
Turmeric / curcumin	Curcuma longa	Meta-analyses of human NAFLD trials disagree on liver-enzyme effect	Modest at best and unconfirmed
Bhumi Amla	Phyllanthus niruri	One 12-month human NAFLD RCT: no change in liver fat or enzymes, but improved a fibrosis marker	Studied in NAFLD; nuanced, not a cure
Triphala	(amla + bibhitaki + haritaki)	Reviews support antioxidant and digestive actions; no NAFLD outcome data	Traditional support only
Arogyavardhini Vati	classical mineral-herbal formula	Traditional liver/digestive use; no verified human NAFLD trial	Traditional, practitioner-only

The sections below explain each grade honestly — including where the data is weaker than the reputation.

---

Kutki (Picrorhiza kurroa) — strong reputation, weak human fatty-liver evidence

Kutki (Picrorhiza kurroa, also written Katuki) is a small Himalayan herb with one of the oldest reputations in Ayurveda for yakrit (liver) support, traditionally used as a bitter, *Pitta*-pacifying liver and digestive herb. Its reputation runs ahead of its human fatty-liver evidence, so it is worth separating the two carefully.

• Animal (preclinical) data for fatty liver is genuinely encouraging, but it is animal data. In a Wistar-rat model of non-alcoholic fatty liver, a standardised P. kurroa extract reversed fatty infiltration of the liver and lowered hepatic lipid content, with the 400 mg/kg dose outperforming the silymarin control [1]. This is a preclinical study in rats and cannot, on its own, support any claim of benefit in people.
• The human trial that exists was in a different liver disease. A randomised, double-blind, placebo-controlled trial of P. kurroa root powder (375 mg three times daily for two weeks) reported significant improvement in bilirubin, SGOT and SGPT — but the patients had acute viral hepatitis, not fatty liver [2]. A result in viral hepatitis does not transfer to NAFLD; the disease, mechanism and course are different.
• Published human NAFLD trials for Kutki are lacking. Researchers are actively studying its translational potential for fatty-liver disease, and reviews summarise that interest [3], but as of writing there is no robust published human NAFLD trial to cite. Treat Kutki as traditionally used and biologically interesting, with human fatty-liver evidence still to come.

Important: for fatty liver, the strongest Kutki data is animal-based and the human data is in a different disease. Treat this as suggestive, not definitive. Kutki is also very bitter and can cause GI upset; the classical liver formulation that contains it (below) is practitioner-prescribed.

---

Turmeric / curcumin (Haldi) — modest, mixed human signal

Turmeric (Curcuma longa) and its active compound curcumin are the most-studied entry on this list for fatty liver in humans, which is exactly why the honest answer is "modest at best, and the studies disagree."

• One meta-analysis found small reductions in liver enzymes. Pooling six randomised controlled trials, researchers reported a modest reduction in ALT (about −7.3 U/L) and AST (about −4.7 U/L) in people with NAFLD, with the effect significant mainly in trials shorter than 12 weeks [4].
• A larger, newer meta-analysis found no such enzyme benefit. A later review of 16 RCTs in 975 patients found no significant reduction in ALT, AST or ALP with curcumin; only triglycerides and waist circumference improved [5]. The two analyses point in different directions, so the honest label for turmeric's liver-enzyme effect in NAFLD is unconfirmed.
• Bioavailability is a real catch. Even reviews that report enzyme reductions flag curcumin's low absorption, poor bioavailability, chemical instability and rapid metabolism — the body simply doesn't take up much of what you swallow [6]. This is why how curcumin is formulated matters; we cover that in our guide to turmeric and curcumin bioavailability.

Important: the human evidence for turmeric in fatty liver is modest and conflicting, and absorption is a genuine limitation. Treat any liver-enzyme benefit as suggestive, not proven. Curcumin may also affect anticoagulant or antiplatelet medication and is not advised in active gallbladder conditions. Speak to your doctor before adding it.

---

Bhumi Amla (Phyllanthus niruri) — the one real human NAFLD trial

Bhumi Amla (Phyllanthus niruri, "stonebreaker") is a small herb traditionally used in Ayurveda for liver and urinary support, and it is the one herb on this list with a genuine, large human trial in fatty liver specifically. The result is nuanced, and answering it honestly matters more than spinning it.

In a randomised, double-blind, placebo-controlled trial, 226 NAFLD patients took 3,000 mg/day of Phyllanthus niruri (or placebo) for 12 months [7]. The findings:

• No significant benefit on liver fat or liver enzymes. There was no meaningful between-group difference in ALT, AST, or the CAP score that estimates liver fat. The herb did not out-perform placebo on these.
• It did significantly improve a fibrosis marker. The same trial found a significant reduction in fibrosis score versus placebo — a measure of liver scarring, distinct from liver fat.

So Bhumi Amla is best described as studied in NAFLD, with a mixed result: it did not reduce liver fat or enzymes, but it improved a fibrosis marker (a promising, honest signal worth mentioning), not a cure.

Important: this is a single trial. One study, however well-conducted, is suggestive rather than definitive, and a fibrosis-marker change is not the same as reversing fatty liver. Treat it as a reason for further research, not a reason to self-prescribe.

---

Triphala and Arogyavardhini Vati — traditional support, no NAFLD outcome data

Two of the most commonly recommended Ayurvedic options for the liver are not herbs with fatty-liver trials at all: they are traditional digestive and classical formulations. They belong here for completeness and honesty.

Triphala is the classical three-fruit blend of amla (Emblica officinalis), bibhitaki (Terminalia bellirica) and haritaki (Terminalia chebula). Reviews support its antioxidant, anti-inflammatory, gut-microbiome and digestive/laxative actions [8], but there is no human NAFLD outcome data. Use it as traditional digestive and antioxidant support, not as a fatty-liver remedy.

Arogyavardhini Vati is a classical Ayurvedic mineral-herbal tablet traditionally indicated for liver and digestive function. There is no verified human NAFLD trial to cite, so it should be described as traditional use only. Critically, many recipes contain processed minerals (including *kajjali*/mercury-based ingredients), which is why it is a practitioner-prescribed formulation — we do not give a self-dosing range for it, and it should only be taken under a qualified Ayurvedic doctor's supervision.

Important: neither has fatty-liver outcome evidence. Triphala is traditional support; Arogyavardhini Vati is practitioner-only because of its mineral content.

---

Why milk thistle and dandelion are not on this list

If you have searched "herbs for fatty liver," you have almost certainly seen milk thistle (silymarin) and dandelion recommended. They are deliberately not on this list — not because they lack interest, but because they are Western and European herbalism, not classical Ayurveda.

This is an "Ayurvedic herbs" guide, so padding it with non-Ayurvedic herbs would be misleading. Milk thistle in particular has its own body of liver research, but it sits outside the Ayurvedic tradition and outside the scope of this article. If a practitioner suggests it, that is a separate, Western-herbal conversation. We are simply being clear about what is and isn't Ayurveda.

---

When NOT to rely on herbs — and "do not self-treat"

Do not self-treat a diagnosed fatty liver. A fatty liver found on a scan or blood test is a medical condition. Take it to your physician (and, if you want to add Ayurvedic support, to a qualified BAMS practitioner) rather than managing it alone with herbs from the internet.

Get medical attention promptly (not herbs) if you have any of these red flags: yellowing of the eyes or skin (jaundice), persistent or worsening pain in the upper-right abdomen, dark urine, unusual fatigue or confusion, or liver enzymes that are rising on repeat tests. These need a doctor now.

• Pregnancy & lactation: evidence for this herb set in pregnancy and breastfeeding is insufficient. Do not use Kutki, Bhumi Amla, concentrated turmeric supplements, or Arogyavardhini Vati during pregnancy or lactation without medical advice. Culinary turmeric in food is a separate matter.
• Drug interactions: turmeric/curcumin may affect anticoagulant and antiplatelet medication. Always check with your doctor before combining any herb with prescription medication — especially diabetes, lipid-lowering, or liver medicines, since fatty liver often travels with these.
• GI sensitivity: Kutki is intensely bitter and may cause nausea or loose stools; Triphala can have a laxative effect.
• Mineral-containing formulations: Arogyavardhini Vati contains processed minerals and is practitioner-only. Never self-dose it.
• Existing liver disease: if you already have liver disease, do not add any herb without your hepatologist's input. Some herbal products have themselves been linked to liver injury.

If you are managing a chronic condition or taking prescription medication, please consult your doctor before starting any new supplement.

---

Our take — how liver-supportive herbs fit a modern Indian routine

At KayaSuddhi, our honest position is the unglamorous one: for fatty liver, the work that moves the needle is lifestyle. Gradual, sustainable weight loss, cutting back on refined carbohydrates and sugary drinks, daily movement, and managing blood sugar and lipids with your doctor — that is the layer with real reversal evidence. Everything herbal sits on top of that, never instead of it.

Within that frame, the Ayurvedic herbs above can be thought of as traditional liver and digestive support: Triphala as a gentle digestive staple, turmeric as a kitchen herb you already cook with, Kutki and Bhumi Amla as practitioner-guided additions. If you want to build a gentle daily routine around herbs like these, our KayaSuddhi digestion range is a sensible starting point. None of them is a "detox" that flushes the liver clean; that is marketing language, not physiology, and we unpack it in our guide to Ayurvedic detox myths and method. For the bigger picture of how diet, herbs and movement fit together for metabolic health, see our complete guide to Ayurvedic weight management.

The most useful thing we can offer right now is a clear-eyed, lifestyle-first routine, and our team's standing advice: take a diagnosed fatty liver to your doctor first, then layer in support thoughtfully and under supervision.

---

Frequently asked questions

Is Bhumi Amla good for fatty liver?

Bhumi Amla (Phyllanthus niruri) is traditionally used for the liver, and it has the one real human NAFLD trial on this list. In a 12-month placebo-controlled study of 226 patients, it did not significantly reduce liver fat or liver enzymes (ALT/AST) versus placebo, but it did improve a fibrosis (scarring) marker [7]. Promising and worth honest mention, but not a proven cure. Use only with medical advice.

Is Kutki good for fatty liver?

Traditionally, yes: Kutki (Picrorhiza kurroa) has a long reputation as a liver herb in Ayurveda. But human fatty-liver evidence is essentially absent. The strongest data is a rat study showing reduced fatty infiltration [1] plus a human trial conducted in viral hepatitis, not NAFLD [2]. Treat it as traditionally used, with human fatty-liver trials still lacking.

Does turmeric help fatty liver?

The human evidence is modest and mixed. One meta-analysis of six trials found small reductions in liver enzymes [4], while a larger, newer review of 16 trials found no significant enzyme benefit [5]. Curcumin is also poorly absorbed. So turmeric may offer modest, unconfirmed support, not a cure. Talk to your doctor before adding curcumin supplements.

Can Triphala help with fatty liver?

There is no human fatty-liver outcome data for Triphala. Reviews support its antioxidant, anti-inflammatory and digestive/gut actions [8], so it is best seen as traditional digestive and antioxidant support rather than a fatty-liver remedy. It can have a laxative effect at higher doses. Use it as part of general wellness, not as a treatment for a diagnosed fatty liver.

What is Arogyavardhini Vati used for?

Arogyavardhini Vati is a classical Ayurvedic mineral-herbal tablet traditionally used to support liver and digestive function. There is no verified human NAFLD trial behind it, so this is a description of traditional use only, not a clinical claim. Because many recipes contain processed minerals (including mercury-based ingredients), it is a practitioner-prescribed formulation and should never be self-dosed; take it only under a qualified Ayurvedic doctor.

Can fatty liver be reversed with Ayurveda?

The intervention with real reversal evidence is lifestyle — sustainable weight loss, a better diet, exercise and managing blood sugar and lipids. Ayurvedic herbs may support liver health as adjuncts, but none is a proven cure and you should not expect herbs alone to reverse fatty liver. Most importantly, do not self-treat a diagnosed fatty liver. See your physician, and work with a qualified practitioner if you want to add Ayurvedic support.

---

Related reading

• Ayurvedic Weight Management: The Complete Guide — the full guide
• Turmeric and Curcumin Bioavailability
• Ayurvedic Detox: Myths and Method

Sources

1. Shetty SN, Mengi S, Vaidya R, Vaidya ADB. A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. J Ayurveda Integr Med. 2010;1(3):203–210. https://doi.org/10.4103/0975-9476.72622 (PMID 21547049)
2. Vaidya AB, Antarkar DS, Doshi JC, et al. Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent — experimental & clinical studies. J Postgrad Med. 1996;42(4):105–108. (PMID 9715310)
3. Raut A, Dhami-Shah H, Phadke A, et al. Picrorhiza kurroa, Royle ex Benth: traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. J Ayurveda Integr Med. 2023;14(1):100558. https://doi.org/10.1016/j.jaim.2022.100558 (PMID 35659739)
4. Goodarzi R, Sabzian K, Shishehbor F, Mansoori A. Does turmeric/curcumin supplementation improve serum ALT and AST levels in patients with NAFLD? A systematic review and meta-analysis of RCTs. Phytother Res. 2019;33(3):561–570. https://doi.org/10.1002/ptr.6270 (PMID 30653773)
5. Malik A, Malik M. Effects of curcumin in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Can Liver J. 2024. https://doi.org/10.3138/canlivj-2023-0022 (PMCID PMC11089474)
6. Ebrahimzadeh A, et al. Therapeutic effects of curcumin supplementation on liver enzymes of NAFLD patients: a systematic review and meta-analysis of RCTs. Food Sci Nutr. 2024. https://doi.org/10.1002/fsn3.4144 (PMCID PMC11716989)
7. Abu Hassan MR, Md Said RH, Zainuddin Z, et al. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Heliyon. 2023;9(6):e16652. https://doi.org/10.1016/j.heliyon.2023.e16652 (PMID 37313177)
8. Peterson CT, Denniston K, Chopra D. Therapeutic Uses of Triphala in Ayurvedic Medicine. J Altern Complement Med. 2017;23(8):607–614. https://doi.org/10.1089/acm.2017.0083 (PMID 28696777)

---

About this content. This article is for educational purposes only and is not medical advice. These statements have not been evaluated by AYUSH or FSSAI as treatment claims. KayaSuddhi products are purely herbal and not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Please consult your physician or a qualified BAMS-certified Ayurvedic practitioner before starting any new supplement — especially if you are pregnant, breastfeeding, on prescription medication, or managing a chronic condition.

---

Want a liver-supportive lifestyle guide?